Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Raloxifene versus isradipine for cognitive deficits in schizophrenia
IRCT2016010225812N1Phase 2Completed
- Sponsor
- Zanjan University of Medical Sciences
- Start
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of raloxifene and Isradipine in schizophrenia and schizoaffective disorder (2 arms), sponsored by Zanjan University of Medical Sciences. Started May 2016; status: completed.
02
Drugs
raloxifeneIsradipine
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on IRCT2016010225812N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016010225812N1.